Posts by UCI Adeline Yen Mah Vaccine Center
Speaker Event: Alvin Yu PhD “Molecular Simulations of HIV-1 Maturation”
Alvin Yu, PhD will be giving a seminar on Molecular Simulations of HIV-1 Maturation. For more info, 🔗 Read More →
Read More2026 Faculty Retreat: Future Directions for Biomedical Research
The 2026 Faculty Research Retreat at the University of California, Irvine School of Medicine spotlighted bold ideas shaping the future of biomedical science. From AI-driven healthcare to breakthroughs in genomics and stem cell research, faculty shared innovations with real-world impact. The event captured UCI’s momentum—and a glimpse of what’s next. 🔗 Read More →
Read MoreNew Findings Reshape Our Understanding of Human T Cell Biology
Scientists at UC Irvine have uncovered a surprising truth about where most of your immune system actually operates—and it’s not where researchers have been looking. This breakthrough challenges long-held assumptions and hints at a much deeper level of complexity in how the body fights disease. What they found could change the future of vaccines and…
Read MoreUC Irvine Receives Initial $33 Million in Federal Support for Vaccine Research
The UCI Vaccines for Pandemic Preparedness Center (VPPC) receives NIH funding to prepare for pandemic threats in the future. The Center will conduct basic and translational research to produce prototype vaccines against members of the Picornaviridae and Peribunyaviridae virus families.
Read MoreAdeline Yen Mah Vaccine Center Director Phil Felgner Awarded Princess of Asturias Award
The Princess of Asturias Foundation convenes the Princess of Asturias Awards, which are presented at an academic ceremony held each year in Oviedo, capital of the Principality of Asturias. The Foundation’s aims are to contribute to extolling and promoting those scientific, cultural and humanistic values that form part of the universal heritage of humanity and…
Read MoreIn the Press: UC Irvine Researchers Launch COVID-19 Antibody Study in Santa Ana
🔗 UC Irvine Researchers Launch COVID-19 Antibody Study in Santa Ana → 🔗 Estimated Seroprevalence of Sars-Cov-2 Antibodies Among Adults in Orange County, California →
Read MoreCoronavirus Publications – 4/18/2020 Two
Our latest SARS-CoV-2 BioRxiv preprints from UC Irvine Adeline Yen Mah Vaccine Center: Analysis of Serologic Cross-Reactivity Between Common Human Coronaviruses and SARS-CoV-2 Using Coronavirus Antigen Microarray Analysis of SARS-CoV-2 Antibodies in COVID-19 Convalescent Plasma using a Coronavirus Antigen Microarray
Read MoreCoronavirus Publications – 4/18/2020 One
đź”— Doctors Race to Develop Coronavirus Drugs, Speeding Through Hurdles → đź”— Nanommune Inc. to Develop and Market a Novel Coronavirus Multiplex Serological Assay → đź”— Could a Blood Test for Coronavirus Antibodies Get California Back to Normal? Lots of Questions Remain → đź”— Where California Stands With Coronavirus Testing Right Now → đź”— Darpa-Funded…
Read MoreUCI Tech Can Provide Better Understanding of COVID-19 and Vaccine Possibilities
Researchers at the University of California, Irvine are advancing new technologies to better understand COVID-19 and speed vaccine development. From antibody testing to immune system mapping, these tools reveal how the body responds to infection. Their work offers promising insights that could shape future pandemic responses.
Read MoreMass Testing Is the Only Sustainable Solution to the Coronavirus
Mass testing is framed as the clearest path to controlling COVID-19 without long-term shutdowns. By identifying who is infected and who has immunity, society can reopen more safely. The approach is ambitious—but it offers a practical way forward. đź”— The U.S. faces two disastrous scenarios. There’s a third option. → A TWiV foursome provides an…
Read More